Table 2

Summary of findings for primary outcome and quality of evidence assessment (GRADE)*

OutcomeFollow-up time-pointNumber of participantsMD (95% CI)†GRADE
General population
Exercise vs control
 Pain intensityShort-term61217 27 34 −4.50 (−7.26 to −1.74)Moderate quality
 DisabilityShort-term18927 −2.36 (−7.11 to 2.39)Very low quality‡
Exercise and education vs control
 Pain intensityShort-term18430 32 36 −1.95 (−10.09 to 6.18)Low quality
 Pain intensityLong-term4718 32 36 40 −4.37 (−9.16 to 0.43)Moderate quality
 DisabilityShort-term15032 36 −4.94 (−12.78 to 2.90)Low quality
 DisabilityLong-term4718 32 36 40 −6.28 (−9.51 to −3.06)Moderate quality
Education vs control
 Pain intensityShort-term77718 29 33 −1.81 (−4.68 to 1.07)Moderate quality
 Pain intensityLong-term1267 40 1.71 (−6.14 to 9.56)Low quality
 DisabilityShort-term80429 33 38 41 −2.59 (−6.15 to 0.96)Moderate quality
 DisabilityLong-term17640 41 −0.29 (−4.87 to 4.30)Low quality
Ergonomics vs control
 Pain intensityShort-term55220 1.40 (−3.28 to 6.08)Low quality‡
 Pain intensityLong-term53820 2.00 (−2.74 to 6.74)Low quality‡
Ergonomics and education vs control
 Pain intensityShort-term19228 1.00 (−6.93 to 8.93)Very low quality‡
 Pain intensityLong-term2667 28 0.00 (−6.70 to 6.70)Low quality
 DisabilityShort-term19228 2.08 (−1.87 to 6.03)Very low quality‡
 DisabilityLong-term18428 1.25 (−3.08 to 5.58)Very low quality‡
Pregnant population
Exercise vs control
 Pain intensityShort-term45221 23 −2.70 (−6.56 to 1.17)High quality
 DisabilityShort-term24021 −2.91 (−7.06 to 1.24)Low quality‡
Children population
Exercise and education vs control
 Pain intensityShort-term7022 0.00 (−11.68 to 11.68)Very low quality‡
  • A negative value of the MD estimate represents an effect in favour of the intervention group.

  • Short-term indicates follow-up assessment of <12 months.

  • Long-term indicates follow-up assessment of 12 months or more.

  • *Only studies providing results that could be converted to a 0–100 scale are presented.

  • †Value presented on 0–100 scale.

  • ‡Quality of evidence assessment based on a single trial.

  • GRADE, Grading of Recommendations Assessment, Development and Evaluation; MD, mean difference.